mRS-话题@MedSci

#mRS#

44篇内容 | 1799人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2054879, encodeId=156820548e92b, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=Expert Rev Anti Infect Ther：抗MRSA的喹诺酮类药物治疗ABSSSIs的效果与其他抗生素类似, objectType=article, longId=727193, objectId=6b2be271938c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b2be271938c, replyNumber=0, likeNumber=94, createdTime=2022-06-15, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b2be271938c, moduleTitle=Expert Rev Anti Infect Ther：抗MRSA的喹诺酮类药物治疗ABSSSIs的效果与其他抗生素类似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b2be271938c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054878, encodeId=de2c20548e80f, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=Neurology：替奈普酶（TNK）在治疗老年大血管闭塞型脑卒显示部分优越性：TNK 0.25 mg/kg 与90天mRS改善、80岁以上患者死亡率降低有关, objectType=article, longId=295241, objectId=243f2952419d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=243f2952419d, replyNumber=0, likeNumber=97, createdTime=2022-12-15, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=243f2952419d, moduleTitle=Neurology：替奈普酶（TNK）在治疗老年大血管闭塞型脑卒显示部分优越性：TNK 0.25 mg/kg 与90天mRS改善、80岁以上患者死亡率降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=243f2952419d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054877, encodeId=c93a20548e765, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=MRS在线粒体脑肌病诊断上有没有意义？, objectType=article, longId=216053, objectId=edeb2160534d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edeb2160534d, replyNumber=0, likeNumber=105, createdTime=2022-06-17, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edeb2160534d, moduleTitle=MRS在线粒体脑肌病诊断上有没有意义？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edeb2160534d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054876, encodeId=4f7920548e673, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=知临集团宣布ALS-4 — 一种旨在治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的首创小分子药物 — 临床I期试验向第一个受试者给药, objectType=article, longId=209317, objectId=8c2720931eef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c2720931eef, replyNumber=0, likeNumber=113, createdTime=2021-05-27, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c2720931eef, moduleTitle=知临集团宣布ALS-4 — 一种旨在治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的首创小分子药物 — 临床I期试验向第一个受试者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c2720931eef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054874, encodeId=73f520548e4b0, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=一种治疗耐甲氧西林的金黄色葡萄球菌（MRSA）感染的新型药物ALS-4：即将开展I期临床, objectType=article, longId=205973, objectId=25542059e345, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25542059e345, replyNumber=0, likeNumber=85, createdTime=2021-02-24, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25542059e345, moduleTitle=一种治疗耐甲氧西林的金黄色葡萄球菌（MRSA）感染的新型药物ALS-4：即将开展I期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25542059e345)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054872, encodeId=567020548e248, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=NEJM：脱菌治疗可减少MRSA携带者之间的出院后感染风险, objectType=article, longId=195040, objectId=366d1950406c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=366d1950406c, replyNumber=0, likeNumber=93, createdTime=2020-09-20, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=366d1950406c, moduleTitle=NEJM：脱菌治疗可减少MRSA携带者之间的出院后感染风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=366d1950406c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054875, encodeId=71f020548e5c5, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=知临集团从加拿大公共卫生局获得启动ALS-4——用于治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的小分子药物——的临床1期试验许可, objectType=article, longId=205999, objectId=0f8e205999ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f8e205999ca, replyNumber=0, likeNumber=105, createdTime=2021-09-19, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f8e205999ca, moduleTitle=知临集团从加拿大公共卫生局获得启动ALS-4——用于治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的小分子药物——的临床1期试验许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f8e205999ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054873, encodeId=a86420548e3f2, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=“超级细菌”MRSA为何如此耐药？基因突变有助于MRSA对抗生素高度耐药, objectType=article, longId=198170, objectId=dbbe1981e07c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbbe1981e07c, replyNumber=0, likeNumber=89, createdTime=2021-03-24, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbbe1981e07c, moduleTitle=“超级细菌”MRSA为何如此耐药？基因突变有助于MRSA对抗生素高度耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbbe1981e07c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054871, encodeId=687920548e136, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=JAMA Intern Med：经验性抗MRSA治疗增加肺炎患者不良预后风险, objectType=article, longId=188394, objectId=4f5a1883949f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f5a1883949f, replyNumber=0, likeNumber=77, createdTime=2020-09-15, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f5a1883949f, moduleTitle=JAMA Intern Med：经验性抗MRSA治疗增加肺炎患者不良预后风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f5a1883949f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054870, encodeId=919b20548e05b, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=JAMA：万古霉素联合抗葡萄球菌β-内酰胺类抗生素治疗MRSA菌血症, objectType=article, longId=187897, objectId=047618e89778, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=047618e89778, replyNumber=0, likeNumber=97, createdTime=2020-05-01, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=047618e89778, moduleTitle=JAMA：万古霉素联合抗葡萄球菌β-内酰胺类抗生素治疗MRSA菌血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=047618e89778)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054869, encodeId=75622054869b7, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=NEJM：MRSA 携带者出院后如何管理？, objectType=article, longId=163250, objectId=8a801632503f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a801632503f, replyNumber=0, likeNumber=101, createdTime=2019-08-20, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a801632503f, moduleTitle=NEJM：MRSA 携带者出院后如何管理？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a801632503f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054866, encodeId=e7792054866ac, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=Semin Arthritis Rheu：心肌纤维化、U-CRP和mRSS升高是系统性硬化症心血管并发症的预测因素, objectType=article, longId=161327, objectId=a8bc16132e57, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8bc16132e57, replyNumber=0, likeNumber=88, createdTime=2019-12-15, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8bc16132e57, moduleTitle=Semin Arthritis Rheu：心肌纤维化、U-CRP和mRSS升高是系统性硬化症心血管并发症的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8bc16132e57)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054865, encodeId=58ae20548658c, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=Chest：培养阴性医源性肺炎抗MRSA降阶梯治疗是否影响结局？, objectType=article, longId=158946, objectId=5674158946bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5674158946bb, replyNumber=0, likeNumber=99, createdTime=2019-04-14, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5674158946bb, moduleTitle=Chest：培养阴性医源性肺炎抗MRSA降阶梯治疗是否影响结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5674158946bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054868, encodeId=8c51205486880, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=J Med Chem：发现新型抗MRSA候选药物, objectType=article, longId=163166, objectId=a53516316660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a53516316660, replyNumber=0, likeNumber=86, createdTime=2019-07-06, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a53516316660, moduleTitle=J Med Chem：发现新型抗MRSA候选药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a53516316660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054867, encodeId=184a205486e8d, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=Clin Infect Dis：流感-MRSA肺炎的重症儿童：万古霉素单药治疗充分吗？, objectType=article, longId=161351, objectId=21231613518b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21231613518b, replyNumber=0, likeNumber=114, createdTime=2019-11-27, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21231613518b, moduleTitle=Clin Infect Dis：流感-MRSA肺炎的重症儿童：万古霉素单药治疗充分吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21231613518b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054864, encodeId=cdb6205486432, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=沙场大点兵：再谈抗MRSA药物治疗, objectType=article, longId=145021, objectId=7cee145021b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cee145021b9, replyNumber=0, likeNumber=79, createdTime=2018-10-24, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cee145021b9, moduleTitle=沙场大点兵：再谈抗MRSA药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cee145021b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054863, encodeId=ae73205486372, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=Front Pharmacol：鳞毛蕨提取物对MRSA具有很好的抗菌活性, objectType=article, longId=142126, objectId=0b0814212688, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b0814212688, replyNumber=0, likeNumber=98, createdTime=2019-02-12, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b0814212688, moduleTitle=Front Pharmacol：鳞毛蕨提取物对MRSA具有很好的抗菌活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b0814212688)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054862, encodeId=5c8e2054862e5, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=MRSA的治疗的新近进展, objectType=article, longId=138003, objectId=2e34138003b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e34138003b2, replyNumber=0, likeNumber=72, createdTime=2018-09-07, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e34138003b2, moduleTitle=MRSA的治疗的新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e34138003b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054861, encodeId=2c592054861dd, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=Pharmacotherapy：治疗MRSA菌血症：达托霉素说明书剂量是理想选择？, objectType=article, longId=132624, objectId=0ea21326249d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ea21326249d, replyNumber=0, likeNumber=86, createdTime=2018-07-01, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ea21326249d, moduleTitle=Pharmacotherapy：治疗MRSA菌血症：达托霉素说明书剂量是理想选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ea21326249d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054859, encodeId=922f205485974, content=<a href='/topic/show?id=250012241d8' target=_blank style='color:#2F92EE;'>#mRS#</a>, objectTitle=Int J Infect Dis：哪些因素增加MRSA BSI患者30日死亡风险？, objectType=article, longId=114493, objectId=23221144934f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23221144934f, replyNumber=0, likeNumber=78, createdTime=2018-01-14, rootId=0, userName=ms8888626721583891, userId=9d8a2500148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23221144934f, moduleTitle=Int J Infect Dis：哪些因素增加MRSA BSI患者30日死亡风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23221144934f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

mRS

2020-05-29

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

Expert Rev Anti Infect Ther：抗MRSA的喹诺酮类药物治疗ABSSSIs的效果与其他抗生素类似

2022-06-15

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

Neurology：替奈普酶（TNK）在治疗老年大血管闭塞型脑卒显示部分优越性：TNK 0.25 mg/kg 与90天mRS改善、80岁以上患者死亡率降低有关

2022-12-15

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

MRS在线粒体脑肌病诊断上有没有意义？

2022-06-17

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

知临集团宣布ALS-4 — 一种旨在治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的首创小分子药物 — 临床I期试验向第一个受试者给药

2021-05-27

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

一种治疗耐甲氧西林的金黄色葡萄球菌（MRSA）感染的新型药物ALS-4：即将开展I期临床

2021-02-24

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

NEJM：脱菌治疗可减少MRSA携带者之间的出院后感染风险

2020-09-20

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

知临集团从加拿大公共卫生局获得启动ALS-4——用于治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的小分子药物——的临床1期试验许可

2021-09-19

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

“超级细菌”MRSA为何如此耐药？基因突变有助于MRSA对抗生素高度耐药

2021-03-24

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

JAMA Intern Med：经验性抗MRSA治疗增加肺炎患者不良预后风险

2020-09-15

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

JAMA：万古霉素联合抗葡萄球菌β-内酰胺类抗生素治疗MRSA菌血症

2020-05-01

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

NEJM：MRSA 携带者出院后如何管理？

2019-08-20

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

Semin Arthritis Rheu：心肌纤维化、U-CRP和mRSS升高是系统性硬化症心血管并发症的预测因素

2019-12-15

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

Chest：培养阴性医源性肺炎抗MRSA降阶梯治疗是否影响结局？

2019-04-14

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

J Med Chem：发现新型抗MRSA候选药物

2019-07-06

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

Clin Infect Dis：流感-MRSA肺炎的重症儿童：万古霉素单药治疗充分吗？

2019-11-27

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

沙场大点兵：再谈抗MRSA药物治疗

2018-10-24

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

Front Pharmacol：鳞毛蕨提取物对MRSA具有很好的抗菌活性

2019-02-12

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

MRSA的治疗的新近进展

2018-09-07

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

Pharmacotherapy：治疗MRSA菌血症：达托霉素说明书剂量是理想选择？

2018-07-01

ms8888626721583891 (审核中...)

前往app查看评论内容

#mRS#

Int J Infect Dis：哪些因素增加MRSA BSI患者30日死亡风险？

2018-01-14

科室
- - 订阅+
  - 更多科室
工具
服务